Loading resource…

American Society of Hematology
The guidelines provide evidence-based recommendations for healthcare professionals managing VTE in patients with cancer. They address various aspects of treatment, including the use of low molecular weight heparin (LMWH) versus unfractionated heparin (UFH), and considerations for outpatient management. The document emphasizes the importance of cost-effectiveness and health equity in treatment decisions.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SICKLECELL GUIDELINES 2025 (2)
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR DIAGNOSIS OF IRON DEFICIENCY
Same clinical topic · Hematology

Guideline for SCD Management - Uganda (2)
Same clinical topic · Hematology

SICKLECELL GUIDELINES 2025-2030
Same clinical topic · Hematology

MANAGEMENT OF TRANSFUSION DEPENDENT THALASSAEMIA (TDT)
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITP
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITP
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR SICKLE CELL DISEASE: STEM CELL TRANSPLANTATION
Same clinical topic · Hematology

GUIDELINES FOR THE MANAGEMENT OF EMERGENCIES AND CRITICAL ILLNESS IN PEDIATRIC AND ADULT PATIENTS WITH SICKLE CELL DISEASE
Same clinical topic · Hematology